BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2014
View Archived Issues
Phase I results for MRX-34, a first-in-class liposome formulated miR-34 mimic
Read More
Sigma-Tau describes novel HSP 90 inhibitor
Read More
Interstitial deletion of 8p23.1 indicates a new causative gene for heterotaxy
Read More
Neuregulin-1 expression correlates with sensitivity to GDC-0032 PI3K inhibitor
Read More
Researchers present a novel method to predict the risk of rejection after heart transplant
Read More
Sym-013 augments response to lung and head and neck cancer tumors
Read More
Multiple studies examine treatment of HCV infection with veruprevir/ritonavir/ombitasvir combination
Read More
Karyopharm initiates phase I trial of selinexor and decitabine in AML
Read More
Kyowa Hakko Kirin begins phase III trials of benralizumab in Japan and South Korea
Read More
Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448
Read More
LDC and Daiichi Sankyo form early drug discovery alliance
Read More
OxThera receives financing to continue key clinical programs
Read More
SOM Biotech and Vall d'Hebron Research Institute team up to develop transthyretin amyloidosis drug
Read More
Dosing begins in phase I/II trial of APR-246 in ovarian cancer
Read More
Phase III trial of Baxter's BAX-111 achieves primary endpoint
Read More
Suglat tablets launched in Japan for type 2 diabetes
Read More
Iconic Therapeutics raises funding for development of AMD therapy
Read More
Epirus Biopharmaceuticals to merge with Zalicus
Read More
New anti-CD3 antibodies disclosed by Regeneron Pharmaceuticals
Read More
Researchers at the University of Washington design novel vaccines for viral infections
Read More
Bristol-Myers Squibb presents new XIAP inhibitors for cancer
Read More
Cleveland BioLabs announces results of CBL-0102 phase I cancer trial
Read More
Chugai to launch trastuzumab emtansine in Japan
Read More
Merck KGaA synthesizes novel FAS inhibitors
Read More
Effimune reports advances in the development of a new class of monoclonal antibodies
Read More
ViiV Healthcare launches dolutegravir in Japan
Read More
